[CASE STUDY]Optimization of Compound Delivery Through Different Devices
Time: 9:30 am
day: Day 2
Details:
- Discussing how the FDA sees the administered dose as the dose placed into the device, stressing the need to optimize compound delivery for accurate dosing
- Highlighting the importance of low delivery efficiency in some devices and its impact on safety margins, raising concerns about the effectiveness of the delivered drug
- Exploring how breath-actuated devices improve bioavailability, understanding how these advancements contribute to enhanced drug delivery efficiency and improved patient outcomes
